Team/Members of the group:

• Dr Nitika Grover, Postdoctoral Researcher 
• Christopher J. Kingsbury, Postdoctoral Researcher
• Asterios Charisiadis, Postdoctoral Researcher
• Elisabeth Sitte, Ph.D. Student 
• Karolis Norvaiša, Ph.D. Student 
• Claire Donohoe, Ph.D. Student 
• Zoi Melissari, Ph.D. Student 
• Piotr Gierlich, Ph.D. Student 
• Harry C. Sample, Ph.D. Student 
• Bhavya Khurana, Ph.D. Student 

Close Collaborators:
Biolitec Pharma, Alpheus Medical 

Main Funders: 
H2020, EIC, IRC, TU Munich 

Active research programmes: 
The Senge group develop novel anti-cancer photomedicines, pioneering strategies in low-collateral/high-effect emerging treatments. We bridge organic chemistry and cell biology with a translational focus, accelerating the availability of these treatment options to market.